Apozeal Pharmaceuticals Inc.
9 drugs in NADAC|9 Generic,0 Brand
Apozeal Pharmaceuticals Inc. lists 9 NDCs in the CMS NADAC file (9 generic, 0 brand), at an average NADAC of $0.04 per unit, with a week-over-week move of -2.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
9
9G / 0B
Avg Price / Unit
$0.0422
$0.01 – $0.12
Avg 7d Change
-2.01%
Across 9 drugs with changes
7d Activity
of 9 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Lactulose market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Osmotic Laxative therapeutic class
Review the broader class where Apozeal Pharmaceuticals Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Apozeal Pharmaceuticals Inc. make?
Apozeal Pharmaceuticals Inc. lists 9 NDCs in the CMS NADAC file — 9 generic and 0 brand products.
What is the average price of Apozeal Pharmaceuticals Inc. drugs?
The average NADAC across Apozeal Pharmaceuticals Inc.'s portfolio is $0.0422 per unit, ranging from $0.0125 to $0.1199.
What types of drugs does Apozeal Pharmaceuticals Inc. make?
Apozeal Pharmaceuticals Inc. makes drugs across 3 FDA pharmacologic classes. The most common by NDC count are Osmotic Laxative (5), Histamine-1 Receptor Antagonist (3), Antihistamine (1).
Has Apozeal Pharmaceuticals Inc. had any drug recalls?
No FDA enforcement recalls are matched to Apozeal Pharmaceuticals Inc. in the openFDA feed.
How has Apozeal Pharmaceuticals Inc.'s pricing changed recently?
Over the past 7 days, 2 Apozeal Pharmaceuticals Inc. products rose and 7 fell, with a portfolio-wide average change of -2.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CETIRIZINE HCL 1 MG/ML SOLN Cetirizine Hydrochloride Oral Solution | $0.1199 per ML | -16.28% |
HYDROXYZINE 10 MG/5 ML SOLN HYDROXYZINE HYDROCHLORIDE | $0.1132 per ML | +3.95% |
CETIRIZINE HCL 1 MG/ML SOLN CETIRIZINE HYDROCHLORIDE | $0.0379 per ML | +1.34% |
LACTULOSE 10 GM/15 ML SOLUTION Lactulose | $0.0224 per ML | -0.13% |
CETIRIZINE HCL 1 MG/ML SOLN Cetirizine Hydrochloride Oral Solution | $0.0223 per ML | -2.06% |
LACTULOSE 10 GM/15 ML SOLUTION Lactulose | $0.0195 per ML | -2.01% |
LACTULOSE 10 GM/15 ML SOLUTION Lactulose | $0.0194 per ML | -1.22% |
LACTULOSE 10 GM/15 ML SOLUTION Lactulose | $0.0130 per ML | -1.29% |
LACTULOSE 10 GM/15 ML SOLUTION Lactulose | $0.0125 per ML | -0.40% |